191 related articles for article (PubMed ID: 5387577)
1. [Clinical use of podophyllinic acid ethylhydrazide (SP-I) and podophyllotoxin-beta-o-benzyliden-glucoside (SP-G) in malignant urologic tumors].
Aso Y; Hoshi Y; Okada K; Koiso K; Murahashi I
Gan No Rinsho; 1969 May; 15(5):453-7. PubMed ID: 5387577
[No Abstract] [Full Text] [Related]
2. [Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors].
Ohara H; Noto J; Kihara A; Noguchi H; Ishii Y
Gan No Rinsho; 1968 Feb; 14(2):96-100. PubMed ID: 5244790
[No Abstract] [Full Text] [Related]
3. [Prevention of experimental arthritis with the cytostatic agent podophyllinic acid ethylhydrazide].
Szántó L; Lörincz G; Gömör B
Arzneimittelforschung; 1968 Jul; 18(7):886-9. PubMed ID: 5756046
[No Abstract] [Full Text] [Related]
4. [Treatment of malignant tumors with SP-I/SP-G Sandoz (Proresid)].
Bîrzu I
Ther Umsch; 1966 Dec; 23(12):522-7. PubMed ID: 5980440
[No Abstract] [Full Text] [Related]
5. [Synergic action of x-rays and of the ethylhydrazide of podophyllinic acid on a solid isologous tumor of the C3H mouse].
Donner M; Oth D; Du Cluzel O; Burg C
C R Seances Soc Biol Fil; 1967 Jul; 161(2):403-7. PubMed ID: 4229149
[No Abstract] [Full Text] [Related]
6. [Favourable response of advanced ovarian cancer to treatment with a podophyllin derivative (SP-I and SP-G)].
Tomin R
Srp Arh Celok Lek; 1965 Oct; 93(10):973-9. PubMed ID: 5872509
[No Abstract] [Full Text] [Related]
7. [Proreside in treatment of malignant neoplasms of the genito-urinary system].
Howorka E; Biczysko R
Wiad Lek; 1967 Feb; 20(3):239-43. PubMed ID: 6040309
[No Abstract] [Full Text] [Related]
8. [Therapeutic effects of podophyllin derivatives on malignant neoplasms].
Diefenthaeler E; Herter NT
Hospital (Rio J); 1968 Jan; 73(1):183-95. PubMed ID: 5308491
[No Abstract] [Full Text] [Related]
9. [Clinical use of podophyllin derivatives SP-I and SP-G in the treatment of cancer].
Kitagawa S; Nishimura K; Motoyama Y; Teramura Y; Hironaka T
Gan No Rinsho; 1968 Dec; 14(12):1057-61. PubMed ID: 5752852
[No Abstract] [Full Text] [Related]
10. [Clinical experiences with SP-I].
Furue H; Koizumi H; Nishi I; Hattori T; Yokoyama T
Gan No Rinsho; 1967 Sep; 13(9):658-62. PubMed ID: 5627165
[No Abstract] [Full Text] [Related]
11. [Clinical observations and results of the treatment of malignant tumors with podophyllim derivatives Sp-I and Sp-G].
Tomov V; Popov G; Stoianov E
Khirurgiia (Sofiia); 1965; 18(6):623-32. PubMed ID: 5886870
[No Abstract] [Full Text] [Related]
12. [Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)].
Motti VJ
Hospital (Rio J); 1968 Oct; 74(4):1377-88. PubMed ID: 5304166
[No Abstract] [Full Text] [Related]
13. [Results of SPI, SPG and combination of radiotherapy in the management of certain tumors].
Uzel R; Adali I; Civelekoğlu E
Turk Tip Cemiy Mecm; 1967 Feb; 33(2):106-16. PubMed ID: 6040938
[No Abstract] [Full Text] [Related]
14. [Studies with Proresid (SP-I) in various transplantable tumors].
Cerletti A; Stähelin H; Schoch J
Med Klin; 1966 Jul; 61(30):1192-4. PubMed ID: 5993141
[No Abstract] [Full Text] [Related]
15. [The association of podophyllum derivatives and cyclophosphamide in the palliative therapy of female pelvic neoplasms].
Varianti G
Cancro; 1965; 18(6):526-41. PubMed ID: 4162232
[No Abstract] [Full Text] [Related]
16. [Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)].
Lipozencić M; Padovan I
Rad Med Fak Zagrebu; 1965; 13(1):57-67. PubMed ID: 5871944
[No Abstract] [Full Text] [Related]
17. [5-year results of combined treatment with the cobalt bomb and the cytostatic preparation SP-G and SP-I (Sandoz)].
Hubacher O
Dtsch Med Wochenschr; 1965 Nov; 90(48):2145-9. PubMed ID: 5844793
[No Abstract] [Full Text] [Related]
18. [Combines cytostatic treatment of malignant tumors. (Clinical histological report of 4 cases)].
Busch W; Goldschmidt F
Krebsarzt; 1967; 22(4):224-33. PubMed ID: 5592995
[No Abstract] [Full Text] [Related]
19. [Experiences with the cytostatic podophyllin therapy].
Halama J
Munch Med Wochenschr; 1967 Feb; 108(7):378-81. PubMed ID: 4862314
[No Abstract] [Full Text] [Related]
20. [Studies with Proresid (SP-I) in various innoculation tumors].
Osswald H; Schmähl D
Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
